This is of particular importance if one considers that long-term sustained activation of β2-AR by sympathetic hyperactivity in HF might lead to β2-AR downregulation and loss of function, which will further aggravate skeletal myopathy in HF. The gene discussed is ADRB2; the disease is Skeletal myopathy.